Resources

2 Resources for

nuvaring

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

NuvaRing(R), World's First Vaginal Birth Control Ring, Now Available In U.S.
(NASDAQ: AKZOY) -- Women now have a unique, effective and convenient new monthly contraceptive option. Organon Inc. today announced that NuvaRingR (etonogestrel/ethinyl estradiol vaginal ring), the world's first monthly vaginal ring for birth control, is now available in pharmacies nationwide. NuvaRingR, is a small flexible, transparent ring that...
Tags: NuvaRing, Organon Inc.
Research articles 1970-01-01
Should We Be Surprised That Schering-Plough Execs Are "Surprised" By Sugammadex Rejection?
Yet another setback for Schering-Plough seems to have taken top management by surprise. Schering’s shares slid nearly four percent by midafternoon on the news that its sugammadex anesthesia-recovery drug would not be approved by the FDA. In a statement, Schering VP Thomas Koestler said he was “surprised...
Tags: Revenue, FDA, Schering-Plough Corp., Diversity, Schering, NuvaRing, Federal Government, Operational Accounting, Government, Finance, Jim Edwards
Blog posts 2008-08-01

Additional Resources

NuvaRing.com Receives Prestigious Award Nomination from International Academy of Digital Arts and Sciences
ROSELAND, N.J., April 26 /U.S. Newswire/ -- NuvaRing.com - the informational web site regarding Organon's innovative method of contraception, NuvaRingr - has been nominated for the Best Pharmaceutical Site of the Year award at the Ninth Annual Webby Awards celebration. The Webby Awards is the leading international award ceremony honoring...
Tags: Organon Inc.
Research articles 2005-04-26
Organon Inc. To Offer Women In U.S. Voucher For One Free Month Of NuvaRing(R)
Women in the U.S. have the opportunity to obtain a voucher for one free NuvaRingR (etonogestrel/ethinyl estradiol vaginal ring) announced Organon Inc., manufacturers of the world's first monthly vaginal ring for birth control. Currently patients can register for free a newsletter and updates at www.nuvaring.com.NuvaRingR, which has already received approval...
Tags: Organon Inc.
Research articles 1970-01-01
Heartbeat Wins AdStar Award for Nuvaring Campaign
NEW YORK -- Pharmaceutical Executive has recognized Heartbeat Digital as a 2006 AdStar for its work on Organon's NuvaRing Online Ad campaign. Organon challenged Heartbeat to integrate online ads with the brand's TV campaign to spur users to download the Free Trial Voucher for Nuvaring, an innovative, low hormone...
Tags: Organon Inc.
Research articles 2006-04-17
Organon's Once-a-Month Contraceptive Ring, NuvaRing(R) Completes European Authorization.
OSS, The Netherlands, June 19 /PRNewswire/ -- Organon announced today that NuvaRingR (etonogestrel/ethinyl estradiol vaginal ring), the company's once-a-month contraceptive, has successfully completed the European Mutual Recognition Procedure MRP in an additional 13 countries (1). NuvaRing is already approved...
Tags: Organon Inc.
Research articles 2007-06-19
Schering's Weird New Nuvaring Ad: "Don't You Have to ... Put It In ...?"
Schering-Plough's new TV commercial for Nuvaring employs a weird strategy -- it features a group of women explaining the old Nuvaring commercial as it plays in the background video below. by Jim Edwards
Tags: Schering-Plough Corp., Schering, Gender And Diversity, Corporate Communications, TVs, Tv & Home Theater, Strategy, Human Resources, Marketing, Personal Technology, Home Entertainment, Management, Jim Edwards
Blog posts 2009-08-25
Schering's Nuvaring Accused in Death; J&J's Ortho Evra Reveals a Worst-Case Scenario
If Schering-Plough wants to know what the future possibly holds for its Nuvaring contraceptive -- accused in lawsuits of killing a woman via a thromboembolism -- it might want to look at what happened with Johnson & Johnson's Ortho Evra birth control patch. by Jim Edwards
Tags: Johnson & Johnson, Schering, Jim Edwards
Blog posts 2009-05-04
NuvaRing DTC ads launched
ORGANON'S DTC campaign for its NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) contraceptive launched nationally in late November, following a pilot in select markets. The campaign, by CommonHealth shop Quantum, includes a 60-second TV commercial running in prime time, daytime and on cable, complemented by print placements in Us Weekly The campaign...
Tags: Organon Inc.
Research articles 2006-01-01
Motley Rice and D'Arcy, Johnson, Shober & Hassell file Lawsuit Alleging Wrongful Death of a 32-Year-Old Mother of Two Using NuvaRing® Contraceptive
Organon USA, Inc. and Numerous Other Defendants Named in Complaint Filed in NJ Superior Court MOUNT PLEASANT, S.C. -- Motley Rice LLC and D'Arcy, Johnson, Shober & Hassell, P.C., have filed a wrongful death and survival action against the makers, manufacturers, distributors and marketers of the contraceptive NuvaRing([R]) alleging...
Tags: Organon Inc.
Research articles 2008-03-20
NuvaRing campaign
Organon USA has launched its first direct-to-consumer advertising campaign for NuvaRing. The initiative is designed to educate consumers on the benefits and risks of the low-dose contraceptive, made in the form of a vaginal ring. The contraceptive is said to protect against pregnancy for an entire month.
Tags: Organon Inc., Organon USA
Research articles 2005-11-21
Hulu Is Starting to Show Itself the Money
This afternoon, I tested out a theory that I've had a few months now: that Hulu is finally really beginning to sell inventory. Time was, as many of you know, that the site was chock full of public service ads, even on its most highly trafficked content; today, in a...
Tags: Advertisement, Advertiser, Hulu, Catharine P. Taylor
Blog posts 2009-10-15
Pfizer, CDM clean up at Doctors' Choice
PROFESSIONAL ADS for Pfizer's Chantix and Organon's NuvaRing were the year's top-rated as judged by physicians in the Association of Medical Media's fifth annual Doctors' Choice Awards.
Tags: Pfizer Inc.
Research articles 2007-11-01
J&J vs. Merck and Schering: Who Is Most Desperate in This Bizarre Love Triangle?
Nobody wants to say anything about the great Remicade tug of war that has broken out between Johnson & Johnson and the soon-to-be-merged Merck and Schering-Plough. A look at the Q1 2009 numbers suggest that each member of this trio has their own reasons to be quietly...
Tags: Revenue, Johnson & Johnson, Merck & Co. Inc., Schering, Remicade, Merger Partner, Operational Accounting, Mergers & Acquisitions, Sales Strategy, Finance, Investment, Sales, Jim Edwards
Blog posts 2009-04-24
Akzo Nobel's pharmaceutical unit flounders. (News: Europe).(Brief Article)
AKZO NOBEL's struggling pharmaceutical operation is cutting production of a new contraceptive because of lower than expected sales in the US. Organon International, the company's main pharmaceutical subsidiary, is switching to other work 60 of the 100 staff members at its plant at Oss, the Netherlands,...
Tags: Akzo Nobel N.V., Organon Inc.
Research articles 2003-04-07
Akzo Nobel unveils plan to combat sales slump
The problem? A sales hiatus, or in Akzo-speak, a 'current temporary slowing in performance', in the pharma businesses. The diagnosis: post-1997 double-digit growth was arrested in the past eight months by the triple-whammy of US dollar and other currency devaluations, generics competition in the US (for the oral contraceptive...
Tags: Akzo Nobel N.V.
Research articles 2002-11-18
Contraceptive gives a new 'ring' to birth control options
WASHINGTON -- The Food and Drug Administration has given approval to a new ring-shaped contraceptive that can be left in a woman's body for three weeks at a time, but most consumers will have to wait until spring to try it. The prescription product, NuvaRing (etonogestrel/ ethinyl estradiol vaginal...
Tags: Organon Inc.
Research articles 2001-11-05
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement